MedTrace Logo

LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment

NCT04999423 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2025-01-07

No results posted yet for this study

Summary

This is a prospective multicenter international single-arm observational study to demonstrate that use of stent-assisted coiling with LVIS™ Evo™ and HydroCoil® Embolic System (HES) in intracranial aneurysm treatment is effective and safe when assessed at 1 year after the procedure

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

LVIS EVO and HydroCoil Embolic System

Stent assisted Coiling

Sponsors & Collaborators

  • Microvention-Terumo, Inc.

    lead INDUSTRY

Principal Investigators

  • Rene Chapot, Prof. · Alfried Krupp Krankenhaus

  • Jonathan Downer, Dr. · Royal Infirmary of Edinburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-14
Primary Completion
2025-03-01
Completion
2026-12-01

Countries

  • Belgium
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04999423 on ClinicalTrials.gov